A lung nodule is a small spot on the lung, usually round, measuring 3 centimeters (about 1.2 inches) or less in diameter. Most lung nodules are not cancer. They show up on CT scans frequently, with reported detection rates ranging from about 6% to 51% of all chest CT scans, and over 1.6 million are found in the United States each year. The vast majority are discovered by accident when imaging is done for an unrelated reason, like a heart workup or an injury.
Why Most Lung Nodules Are Not Cancer
The most common type of lung nodule is an infectious granuloma, a tiny cluster of immune cells that forms when your body fights off an infection. Fungal lung infections and tuberculosis are frequent culprits. You may have had the infection years ago, cleared it without ever knowing, and what remains is essentially a scar your immune system left behind.
Other non-cancerous causes include:
- Autoimmune granulomas: Conditions like rheumatoid arthritis and sarcoidosis can trigger small clusters of inflamed tissue in the lungs.
- Benign tumors: Hamartomas (the most common benign lung tumor), lipomas, and adenomas can all appear as nodules.
- Lung scarring: Smoking, exposure to chemicals or irritants, and past lung infections can leave behind small areas of scar tissue that show up as nodules on a scan.
Any growth in the lung larger than 3 centimeters is classified as a mass rather than a nodule, and masses are treated as potentially cancerous until proven otherwise. That size cutoff matters because it changes how urgently your doctor will investigate.
How Lung Nodules Are Found
Lung nodules almost never cause symptoms. They don’t typically make you cough, feel short of breath, or cause pain. That’s why they’re nearly always discovered incidentally, meaning a doctor ordered a CT scan for something else entirely and the nodule appeared on the image. With more than 93 million CT scans performed annually in the U.S., these incidental findings have become extremely common.
What Makes a Nodule Higher or Lower Risk
Once a nodule is found, your doctor evaluates several features to estimate the likelihood that it could be cancerous. Size is the single biggest factor: nodules under 6 millimeters carry very low risk, while those over 8 millimeters warrant closer investigation. But size alone doesn’t tell the whole story.
Characteristics that raise concern include older age, a significant smoking history, irregular or spiky (spiculated) borders on the scan, uneven internal density, and location in the upper lobes of the lung. Characteristics that lower concern include younger age, little or no smoking history, smooth round edges, small size, and location outside the upper lobes.
Certain patterns visible on CT also help. Nodules with specific types of calcification, such as a dense center, a layered (concentric) pattern, or a “popcorn” pattern, are almost always benign. A nodule that looks completely solid on a scan is evaluated differently from one that appears hazy or partly see-through, known as a ground-glass or part-solid nodule.
Solid vs. Ground-Glass Nodules
On a CT scan, a solid nodule looks like a dense white spot. A ground-glass nodule appears hazy, like frosted glass, meaning you can still partially see through it to the lung tissue behind it. Part-solid nodules have both a hazy area and a solid component.
These distinctions affect how the nodule is monitored. Small ground-glass nodules under 6 millimeters generally don’t require any follow-up imaging at all. Larger ground-glass and part-solid nodules do need surveillance, and those over 8 millimeters are managed similarly to large solid nodules, potentially requiring advanced imaging or a biopsy. Part-solid nodules that persist over time can carry a meaningful cancer risk, so they tend to be watched more carefully than pure ground-glass nodules of the same size.
What Follow-Up Looks Like
If you’ve been told you have a lung nodule, your follow-up plan depends almost entirely on its size and your personal risk profile. The Fleischner Society guidelines, widely used by doctors, break it down into three size categories.
For small nodules under 6 millimeters, low-risk patients often need no follow-up at all. Higher-risk patients may get a single follow-up CT scan at 12 months. If the nodule hasn’t changed, monitoring typically stops there.
For medium nodules between 6 and 8 millimeters, a follow-up CT is usually recommended at 6 to 12 months. If the nodule remains stable, a second follow-up scan at 18 to 24 months may be suggested, especially for higher-risk patients. The goal is to confirm the nodule isn’t growing.
For larger nodules over 8 millimeters, the approach gets more involved. Options include a follow-up CT at three months to check for growth, a PET scan (which highlights metabolically active tissue and can help distinguish cancer from benign tissue), or a biopsy to sample the tissue directly. If the estimated probability of cancer is high, based on all the risk factors combined, a surgical biopsy or removal may be recommended without extended waiting.
What “Stable” Means and Why It Matters
The core principle behind lung nodule monitoring is simple: cancerous nodules grow, and benign ones don’t. A nodule that stays the same size over one to two years of repeat imaging is overwhelmingly likely to be benign. That’s why follow-up plans involve repeat CT scans spaced months apart. Your doctor is comparing the new images to the old ones, measuring the nodule down to the millimeter.
This watch-and-wait approach can feel stressful, but it exists because most nodules are harmless, and jumping straight to a biopsy for every small nodule would expose far more people to the risks of an invasive procedure than it would help. The monitoring timeline is designed to catch the rare nodule that does turn out to be cancerous early enough for effective treatment, while sparing the majority of people from unnecessary intervention.
If a Biopsy or Further Testing Is Needed
When a nodule is large enough or suspicious enough to warrant more than monitoring, the next step is usually a PET scan or a biopsy. A PET scan is noninvasive: you receive an injection of a small amount of radioactive sugar, and the scan highlights areas in the body that are consuming energy at a high rate, which cancer cells tend to do. It’s useful for nodules where the cancer risk is moderate, roughly in the 5% to 65% probability range.
If the PET scan is inconclusive or the probability of cancer is high, a biopsy provides a definitive answer. This can be done with a needle inserted through the chest wall, guided by a CT scanner, or through a bronchoscope (a thin tube passed through the airways). The tissue sample is then examined under a microscope. For nodules with a very high likelihood of being cancerous, your doctor may recommend going straight to surgical removal, which serves as both diagnosis and treatment in one step.